Immunocytochemical localization of dopamine-β-hydroxylase in neurons of the human brain stem
Reference (18)
- et al.
Human plasma dopamine-β-hydroxylase: purification and properties
J. biol. Chem.
(1978) - et al.
Loss of pigmented dopamine-β-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type
Neurosci. Lett.
(1983) - et al.
Adrenergic neurons in human brain demonstrated by immunohistochemistry with antibodies to phenylethanolamine-N-methyl-transferase (PNMT): Discovery of a new group in the nucleus tractus solitarius
Neurosci. Lett.
(1985) - et al.
Laminar, tangential, and regional organization of the noradrenergic innervation of monkey cortex: Dopamine-β-hydroxylase immunohistochemistry
Brain Res. Bull.
(1982) - et al.
Tyrosine hydroxylase immunocytochemistry in human brain
Brain Res.
(1979) - et al.
Noradrenergic projections to the spinal cord of the rat
Brain Res.
(1983) - et al.
Origins and terminations of descending noradrenergic projections to the spinal cord of monkey
Brain Res.
(1984) The Brain Stem of the Cat
(1968)A brainstem atlas of catecholaminergic neurons in man, using melanin as a natural marker
J. comp. Neurol.
(1981)
Cited by (37)
The effect of interactions between genetics and cannabis use on neurocognition. A review
2018, Progress in Neuro-Psychopharmacology and Biological PsychiatryCitation Excerpt :AKT is a serine/threonine protein kinase, identified as a key signaling intermediary downstream of dopamine D2 receptor (Zheng et al., 2012). DBH catalyses the conversion of dopamine to noradrenaline (Kemper et al., 1987). DBH knockout mice show a lack of noradrenaline and also of dopamine in several brains areas, due to interaction between noradrenergic and dopaminergic systems (Schank et al., 2006).
The dopamine b-hydroxylase 19 bp insertion/deletion polymorphism was associated with first-episode but not medicated chronic schizophrenia
2012, Journal of Psychiatric ResearchCitation Excerpt :Dysfunction in the dopaminergic system has been reported to be a key component to the pathophysiology of schizophrenia (Davis et al., 1991) as well as disturbances in central noradrenergic neurotransmission (Klimek et al., 1999; Gu, 2002). Dopamine beta-hydroxylase (DBH) is a key enzyme catalyzing the conversion of dopamine to noradrenaline within these neurons (Cimarusti et al., 1979; Kemper et al., 1987). The level of DBH protein is under strong genetic control and has a significant correlation between its activity in plasma and cerebrospinal fluid (CSF) (Dunnette and Weinshilboum, 1976; Wilson et al., 1988; Cubells et al., 2011).
Lack of association between genetic polymorphisms affecting sympathetic activity and tilt-induced vasovagal syncope
2010, Autonomic Neuroscience: Basic and ClinicalHeterogeneous dopamine populations project to specific subregions of the primate amygdala
2010, NeuroscienceCitation Excerpt :Double-labeled cells were only seen in the main locus coeruleus (A7) and A5 group. Retrograde injections into all of the amygdaloid nuclei, except for the amygdalostriatal area, resulted in bilaterally double-labeled cells in the A5 and A7 groups, which are noradrengeric (Kemper et al., 1987). Anterogradely labeled terminal fiber patterns were similar for injections in the medial A9-SNpc (J15FR) and the A8-RRF (J16FS, J19FS), consistent with retrograde results.
Aromatic l-amino acid decarboxylase-immunoreactive structures in human midbrain, pons, and medulla
2009, Journal of Chemical NeuroanatomyAssociation between a 19 bp deletion polymorphism at the dopamine beta-hydroxylase (DBH) locus and migraine with aura
2006, Journal of the Neurological Sciences